Physician profile
Diego Moreno
NPI 1245761782
$1,558.36
in general payments reported to CMS, 2019-2025
16 companies · $214 in 2025
The $214 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $124 · 2023: $96.52 · 2024: $1,124 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $748 · Food and Beverage: $686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $748.44 |
| Food and Beverage | $685.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $748.44 | 2024 | |
| Bolton Medical INC | $144.90 | 2025 | Gelweave, Relay Thoracic Stent-Graft With Plus Delivery System |
| Supernus Pharmaceuticals, INC. | $116.00 | 2024 | Qelbree |
| Lilly USA, LLC | $94.05 | 2021-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $65.57 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Exact Sciences Corporation | $59.64 | 2023-2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $51.44 | 2024-2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.31 | 2021-2025 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $48.37 | 2023-2024 | Rexulti |
| Abbott Laboratories | $40.90 | 2023-2024 | Proclaim |
| Mylan Specialty L.P. | $39.76 | 2021 | |
| Novo Nordisk INC | $33.60 | 2021-2024 | Wegovy |
| Dexcom, INC. | $20.38 | 2024 | Dexcom G6 Transmitter |
| Takeda Pharmaceuticals U.S.A., INC. | $18.18 | 2024 | Trintellix |
| Currax Pharmaceuticals LLC | $14.19 | 2024 | Contrave |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $13.63 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diego Moreno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.